Alcohol intake and psoriasis

Clinics in Dermatology

Volumn 17, Issue 4, 1999, Pages 423-430

  Wolf, Ronni ^a   Wolf, Danny ^b   Ruocco, Vincenzo ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b Pediatric Outpatient Clinic   (Israel)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYCLIC AMP; CYTOKINE; ORNITHINE DECARBOXYLASE; POLYAMINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE C;

ALCOHOL CONSUMPTION; ALCOHOLISM; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; IMMUNE SYSTEM; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSORIASIS; RISK FACTOR;

ALCOHOLISM; ETHANOL; HUMANS; PSORIASIS; SKIN;

EID: 0032884228     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(99)00028-0     Document Type: Conference Paper

References (109)

1. Krueger G.G., Duvic M. Epidemiology of psoriasis Clinical issues . J Invest Dermatol. 102:1994;14S-18S.
2. Naldi L., Tognoni G., Cainelli T. Analytic epidemiology in psoriasis. J Invest Dermatol. 102:1994;19S-23S.
3. Köbner H. Klinische, experimentelle un therapeutische Mitteilungen uber Psoriasis. Berlin Klin Wochenschr. 21:1878;631-632.
4. Eyre R.W., Krueger G.G. The Köbner response in psoriasis. Roenigk H.H., Maibach H.I. Psoriasis. 1985;105-116 Marcel Dekker, New York.
5. Tagami H. Triggering factors. Clin Dermatol. 15:1997;677-685.
6. Rosenberg E.W., Noah P.W., Zanolli M.D., et al. Use of rifampin with penicillin and erythromycin in the treatment of psoriasis Preliminary report . J Am Acad Dermatol. 14:1986;761-764.
7. Holzman H., Krapp R., Hoede N., et al. Exo- and endogenous provocation of psoriasis. Arch Dermatol Res. 249:1974;1-12.
8. Obuch M.L., Maurer T.A., Becker B., et al. Psoriasis and human immunodeficiency virus infection. J Am Acad Dermatol. 27:1992;1622-1632.
9. Mahoney S.E., Duvic M., Nickoloff B.J., et al. Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma. J Clin Invest. 88:1991;174-185.
10. Abel E.A., DiCicco L.M., Orenberg E.K., et al. Drugs in exacerbation of psoriasis. J Am Acad Dermatol. 15:1986;1007-1022.
11. Wolf R., Lo Schiavo A. Is transglutaminase the mediator between antimalarial drugs and psoriasis? Int J Dermatol. 36:1997;10-13.
12. Seville R.H. Psoriasis and stress. Br J Dermatol. 97:1977;18-21.
13. Gaston L., Lasonde M., Bernier-Buzzanga J., et al. Psoriasis and stress A prospective study . J Am Acad Dermatol. 17:1987;82-86.
14. Ros A.M., Ennerstern G. Photosensitive psoriasis - clinical findings and phototest results. Photodermatology. 3:1986;317-326.
15. Ros A.M., Eklund G. Photosensitive psoriasis. J Am Acad Dermatol. 17:1987;752-758.
16. Murphy F.R., Stolman L.P. Generalized pustular psoriasis. Arch Dermatol. 115:1979;1215-1216.
17. Dunna S.F., Finlay A.Y. Psoriasis Improvement during and worsening after pregnancy . Br J Dermatol. 120:1989;584.
18. Stewart A.F., Battaglini-Sabetta M., Millstone L. Hypocalcemia-induced pustular psoriasis von Zumbusch. Ann Intern Med. 100:1984;677-680.
19. Paton A., Saunders J.B. ABC of alcohol Definitions . Br Med J. 1981;1248-1250.
20. Khavari K.A., Farber P.D. A profile instrument for the quantification and assessment of alcohol consumption The Khavari Alcohol Test . J Stud Alcohol. 39:1978;1525-1539.
21. Magruder Habib K., Stevens H.A., Alling W.C. Relative performance of the MAST, VAST, and CAGE versus DSM-III-R criteria for alcohol dependence. J Clin Epidemiol. 46:1993;435-441.
22. Istvan J., Matarazzo J.D. Tobacco, alcohol and caffeine use A review of their interrelationships . Psychol Bull. 95:1984;301-326.
23. Torabi M.R., Bailey W.J., Majd-Jabbari M. Cigarette smoking as a predictor of alcohol and other drug use by children and adolescents: Evidence of a "gateway drug effect." J Sch Health. 63:1993;302-306.
24. Steptoe A., Wardle J., Pollard T.M., et al. Stress, social support and health-related behavior A study of smoking, alcohol consumption and physical exercise . J Psychosom Res. 41:1996;171-180.
25. Roske I., Baeger I., Frenzel R., et al. Does a relationship exist between the quality of stress and the motivation to ingest alcohol? Alcohol. 11:1994;113-124.
26. Jarrett N., Peatfield R., Glover V. Red wine is less stress reducing than vodka; no differences in neuroendocrine challenge test. J Psychopharmacol (Oxf). 11:1997;283-286.
27. Ginsburg I.H., Link B.G. Psychosocial consequences of rejection and stigma feelings in psoriatic patients. Int J Dermatol. 32:1993;587-591.
28. Lomholt G. Psoriasis, prevalence, spontaneous course and genetics A census study on the prevalence of skin diseases in the Faroe Islands . 1963;GEC Gad, Copenhagen.
29. Texon M. Medical aspects of an alcoholic service in a general hospital Report of 500 cases . Q J Stud Alcohol. 11:1950;205.
30. Rosset M., Oki G. Skin diseases in alcoholics. Q J Stud Alcohol. 32:1971;1017-1024.
31. Berge G., Lundquist A., Rorman H., et al. Liver biopsy in psoriasis. Br J Dermatol. 82:1970;250-253.
32. Ryan T.J., Sadler G.H., Guerrier C., et al. Methotrexate hepatotoxicity in psoriasis. Br Med J. 2:1972;296.
33. Delaney T.J., Lepperd B. Alcohol intake and psoriasis. Acta Derm Venereol (Stockh). 54:1974;237-238.
34. Grunnet E. Alcohol consumption in psoriasis. Dermatologica. 149:1974;136-139.
35. Margolis J., Roberts D.M. Frequency of skin lesions in chronic drinkers (letter). Arch Dermatol. 112:1976;1326-1327.
36. Holt S., Stewart I.C., Dickson J.M.J., et al. Alcohol and the emergency service patient. Br Med J. 281:1980;638-640.
37. Baugman RD, Landee RH, Maloney ME, et al. Psoriasis and alcohol. In: Farber EM, Cox AJ, Nall L, et al., editors. Psoriasis. Proceedings of the Third International Symposium, Stanford University, 1981. New York: Grune & Stratton, 1982:323.
38. Parish L.C., Fine E. Alcoholism and skin disease. Int J Dermatol. 24:1985;300-301.
39. Higgins E.M., du Vivier A.W.P. Alcohol and the skin. Alcohol Alcohol. 27:1992;595-602.
40. Higgins E.M., du Vivier A.W.P. Cutaneous disease and alcohol misuse. Br Med Bull. 50:1994;85-98.
41. Higgins E.M., du Vivier A.W.P., Peters T.J. Drinking habits of patients with psoriasis. Clin Sci. 84:1993;33.
42. Chaput J.C., Poynard T., Naveau S., et al. Psoriasis, alcohol and liver disease. Br Med J. 291:1985;25.
43. Morse R.M., Perry H.O., Hurt R.D. Alcoholism and psoriasis. Alcohol Clin Exp Res. 9:1985;396-399.
44. Monk B.E., Neill S.M. Alcohol consumption and psoriasis. Dermatologica. 173:1986;57-60.
45. Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged urban, native Swedes. Dermatologica. 172:1986;298-304.
46. Nall L. Epidemiology of psoriasis: A global view. In: Farber EM, Nall L, Morhenn V, et al., editors. Psoriasis. Proceedings of the Fourth International Symposium, Stanford University, 1986. New York: Elsevier, 1987:265.
47. Mellor S. Nomogram for calculating amount of alcohol in different beverages. Br Med J. 3:1970;703.
48. Braathen L.R., Botten G., Bjerkedal T. Psoriatics in Norway. A questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venereol Suppl (Stockh). 142:1989;9-12.
49. Zamboni S., Zanetti G., Grosso G., et al. Dietary behaviour in psoriatic patients. Acta Derm Venereol Suppl (Stockh). 146:1898;182-183.
50. Higgins E.M., Peters T.J., du Vivier A.W.P. Smoking, drinking and psoriasis. Br J Dermatol. 129:1993;749-750.
51. Stern R.S., Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis 10 years' prospective experience in a cohort of 1380 patients . J Invest Dermatol. 91:1988;197-201.
52. Poikolainen K., Reunala T., Karvonen J., et al. Alcohol intake A risk factor for psoriasis in young and middle-aged men? Br Med J. 300:1990;780-783.
53. Poikolainen K., Reunala T., Karvonen J. Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol. 130:1994;473-477.
54. Naldi L., Parazzini F., Brevi A., et al. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol. 127:1992;212-217.
55. Duffy D.L., Spelman L.S., Martin N.G. Psoriasis in Australian twins. J Am Acad Dermatol. 29:1993;428-434.
56. Gupta M.A., Gupta A.K. Psoriasis and sex A study on moderately to severely affected patients . Int J Dermatol. 36:1997;259-262.
57. Knopf B., Geyer A., Roth H., et al. The effect of endogenous and exogenous factors on psoriasis vulgaris A clinical study . Dermatol Monatsschr. 175:1989;242-246.
58. Gupta M.A., Schork N.J., Gupta A.K., et al. Alcohol intake and treatment responsiveness of psoriasis A prospective study . J Am Acad Dermatol. 28:1993;730-732.
59. Higgins E.M., du Vivier A.W.P. Alcohol abuse and treatment resistance in skin disease (letter). J Am Acad Dermatol. 30:1994;1048.
60. Vincenti G.E., Blunden S.M. Psoriasis and alcohol abuse. J R Army Med Corps. 133:1987;77-78.
61. Ockenfels H.M., Morsches B., Schopf R.E. Chloroquine, ethanol and indomethacin affect lymphocyte proliferation in patients with psoriasis (abstr). J Invest Dermatol. 100:1993;216.
62. Schopf R.E., Ockenfels H.M., Morshes B. Ethanol enhances the mitogen-driven lymphocyte proliferation in patients with psoriasis. Acta Derm Venereol (Stockh). 76:1996;260-263.
63. Ockenfels H.M., Keim-Maas C., Funk R., et al. Ethanol enhances the INF-γ, TGF-α and IL-6 secretion in psoriatic co-cultures. Br J Dermatol. 135:1996;746-751.
64. Baker R.C., Jerrells T.R. Recent developments in alcoholism Immunological aspects . Recent Dev Alcohol. 11:1993;249-271.
65. Jareo P.W., Preheim L.C., Gentry M.J. Ethanol ingestion impairs bactericidal mechanisms against Streptococcus pneumoniae. Alcohol Clin Exp Res. 20:1996;1646-1652.
66. Wagner F., Fink R., Hart R., et al. Ethanol inhibits interferon-gamma secretion by human peripheral lymphocytes. J Stud Alcohol. 53:1992;277-280.
67. D'Souza N.B., Mandujano J.F., Nelson S., et al. Alcohol ingestion impairs host defenses predisposing otherwise healthy mice to Pneumocystis carinii infection. Alcohol Clin Exp Res. 19:1995;1219-1225.
68. Nair M.P., Schwartz S.A., Kronfol Z.A., et al. Suppression of tumor necrosis factor production by alcohol in lipopolysaccharide-stimulated culture. Alcohol Clin Exp Res. 18:1994;602-607.
69. Laso F.J., Lapena P., Madruga J.I., et al. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism Relationship with liver disease and ethanol intake . Alcohol Clin Exp Res. 21:1997;1226-1231.
70. Reynolds N.J., Yi J.Y., Fisher G.J., et al. Down-regulation of Langerhans cell protein kinase C-beta isoenzyme expression in inflammatory and hyperplastic dermatoses. Br J Dermatol. 133:1995;157-167.
71. Tournier S., Gerbaud P., Anderson W.B., et al. Post-translational abnormality of type II cyclic AMP-dependent protein kinase in psoriasis Modulation by retinoic acid . J Cell Biochem. 57:1995;647-654.
72. Fisher G.J., Tavakkol A., Leach K., et al. Differential expression of protein kinase C isoenzymes in normal and psoriatic adult human skin Reduced expression of protein kinase C-beta II in psoriasis . J Invest Dermatol. 101:1993;553-559.
73. Brion D.E., Raynaud F., Plet A., et al. Deficiency of cyclic AMP-dependent protein kinases in human psoriasis. Proc Natl Acad Sci U S A. 83:1986;5272-5276.
74. Beeker K.R., Lee R.C., Phung H.M., et al. Genetically determined alcohol preference and cyclic AMP binding proteins in mouse brain. Alcohol Clin Exp Res. 14:1990;158-164.
75. Smith C.P. Jr, King B.R., Pennington S.N. Cyclic AMP-dependent protein kinase activity in the brains of alcohol-preferring (P) and nonpreferring (NP) rats. Alcohol. 8:1991;329-332.
76. Shibley I.A. Jr, Carver F.M., Pennington S.N. Ethanol differentially affects metabolic processes in chick embryonic cells. Alcohol Clin Exp Res. 21:1997;460-466.
77. Steiner J., Kirsteins L., LaPaglia N., et al. The effect of acute ethanol (EtOH) exposure on protein kinase C (PKC) activity in anterior pituitary. Alcohol. 14:1997;209-211.
78. Messing R.O., Petersen P.J., Henrich C.J. Chronic ethanol exposure increases levels of protein kinase C delta and epsilon and protein kinase C-mediated phosphorylation in cultured neural cells. J Biol Chem. 266:1991;23428-23432.
79. Hoek J.B., Rubin E. Alcohol and membrane-associated signal transduction. Alcohol Alcohol. 25:1990;143-156.
80. Deitrich R.A., Bludeau P., Elk M.E., et al. Effect of administered ethanol on protein kinase C in human platelets. Alcohol Clin Exp Res. 20:1996;1503-1506.
81. Yang X., Diehl A.M., Wang G.S. Ethanol exposure alters the phosphorylation of cyclic AMP responsive element binding protein and cyclic AMP responsive element binding activity in rat cerebellum. J Pharmacol Exp Ther. 278:1996;338-346.
82. Smith T.L., Bitrick M.S. Ethanol enhances in situ phosphorylation of MARCKS and protein kinase C activity in primary cultures of astrocytes. Life Sci. 58:1996;855-860.
83. Camp RDR. Psoriasis. In: Champion RH, Burton JL, Ebling FJG, editors. Rook, Wilkinson, Ebling Textbook of Dermatology. 5th ed. Oxford: Blackwell Scientific Publications, 1992:1391-1457.
84. Voorhees J.J. Commentary Cyclic adenosine monophosphate regulation of normal and psoriatic epidermis . Arch Dermatol. 118:1982;869-874.
85. Nagy L.E., Diamond I., Collier K., et al. Adenosine is required for ethanol-induced heterologous desensitization. Mol Pharmacol. 36:1989;744-748.
86. Hoffman P.L., Tabakoff B. Ethanol and guanine nucleotide binding proteins A selective interaction . FASEB J. 4:1990;2612-2622.
87. Rabe C.S., Giri P.R., Hoffman P.L., et al. Effect of ethanol on cyclic AMP levels in intact PC12 cells. Biochem Pharmacol. 40:1990;565-571.
88. Luthin G.R., Tabakoff B. Activation of adenylyl cyclase by alcohols requires the nucleotide-binding protein. J Pharmacol Exp Ther. 288:1984;579-587.
89. Hoffman P.L., Moses F., Tabakoff B. Selective inhibition by ethanol of glutamate-stimulated cyclic GMP production in primary cultures of cerebellar granule cells. Neuropharmacology. 28:1989;1239-1243.
90. Diamond I., Wrubel B., Estrin W., et al. Basal and adenosine receptor-stimulated levels of cAMP are reduced in lymphocytes from alcoholic patients. Proc Natl Acad Sci U S A. 84:1987;1413-1416.
91. McDonald C.J. Polyamines in psoriasis. J Invest Dermatol. 81:1983;385-387.
92. Lowe J.N., Breeding J., Russell D. Cutaneous polyamines in psoriasis. Br J Dermatol. 107:1982;21-25.
93. Bouclier M., Elbaze P., Milano G., et al. Hyper-induction of skin ornithine decarboxylase activity in psoriatic patients. Br J Dermatol. 115:1986;193-198.
94. Tanake T., Nishiguchi S., Kuroki T., et al. Effects of single ethanol administration on hepatic ornithine decarboxylase induction and polyamine metabolism. Hepatology. 14:1991;696-700.
95. Diehl A.M., Abdo S., Brown N. Supplemental putrescine reverses ethanol-associated inhibition of liver regeneration. Hepatology. 12:1990;633-637.
96. Diehl A.M., Wells M., Brown N.D., et al. Effect of ethanol on polyamine synthesis during liver regeneration in rats. J Clin Invest. 85:1990;385-390.
97. Klein R.F., Carlos A.S. Inhibition of osteoblastic cell proliferation and ornithine decarboxylase activity by ethanol. Endocrinology. 136:1995;3406-3411.
98. Shibeley I.A. Jr, Gavigan M.D., Pennington S.N. Ethanol's effect on tissue polyamines and ornithine decarboxylase activity A concise review . Alcohol Clin Exp Res. 19:1995;209-215.
99. Eilliams M.L. Epidermal lipids and scaling diseases of the skin. Semin Dermatol. 11:1992;169-175.
100. Harris I.R., Farrel A.M., Grunfeld C., et al. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid and ceramide synthesis in the epidermis. J Invest Dermatol. 109:1997;783-787.
101. Fiengold K.R., Mao-Qiang M., Menon G.K., et al. Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest. 86:1990;1738-1745.
102. Feingold K.R., Mao Quiang M., Proksch E., et al. The lovastatin-treated rodent A new model of barrier disruption and epidermal hyperplasia . J Invest Dermatol. 96:1991;201-209.
103. Cluette J.E., Mulligan J.J., Noring R., et al. Ethanol enhances de novo synthesis of high-density lipoprotein cholesterol. Proc Soc Exp Biol Med. 176:1984;508-511.
104. Mezey E. Metabolic effects of alcohol. Fed Proc. 44:1985;134-138.
105. Field F.J., Boydstun J.S., LaBrecque D.R. Effect of chronic ethanol ingestion on hepatic and intestinal acyl coenzyme-a:cholesterol achyltransferase and 3-hydroxy-3 methylglutaryl coenzyme-a reductase in the rat. Hepatology. 5:1985;133-138.
106. Maruyama S., Murawaki Y., Hirayama C. Effects of chronic ethanol administration on hepatic cholesterol and bile acid synthesis in relation to serum high-density lipoprotein cholesterol in rats. Res Commun Chem Pathol Pharmacol. 53:1986;3-21.
107. Wolf R., Lo Schiavo A., Lombardi M.L., et al. The in vitro effect of hydroxychloroquine on skin morphology and transglutaminase. Int J Dermatol. 36:1997;704-707.
108. Sessa A., Tunici P., Rabellotti E., et al. Transglutaminase activity in rat brain after ethanol exposure. Alcohol Clin Exp Res. 21:1997;1241-1245.
109. Sessa A., Tunici P., Perilli E., et al. Transglutaminase activity in rat liver after acute ethanol administration. Biochim Biophys Acta. 1245:1995;371-375.